Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Arrhythmia Market Value Growth And Long-Term Outlook#_x000D_
The arrhythmia market has demonstrated substantial expansion in recent years. It is anticipated to grow from $8.28 billion in 2025 to $9.03 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.0%. Historically, this market’s growth can be ascribed to the increasing prevalence of cardiovascular diseases, a rising aging population, enhanced availability of diagnostic cardiac devices, growing awareness regarding heart rhythm disorders, and the expansion of hospital cardiology departments._x000D_
_x000D_
The arrhythmia market size is anticipated to experience substantial growth in the upcoming years, projected to reach $12.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.8%. This expansion over the forecast period is propelled by factors such as the increasing embrace of remote patient monitoring solutions, escalating investments in digital cardiology platforms, a heightened demand for early-stage arrhythmia detection, the broadening scope of home-based cardiac care, and continuous technological progress in cardiac diagnostics. Noteworthy trends during the forecast period include the increasing integration of AI-based arrhythmia detection tools, a rising reliance on wearable and remote cardiac monitoring devices, the expanding integration of digital ECG and Holter technologies, the evolution of personalized arrhythmia treatment approaches, and an intensified focus on early diagnosis and continuous monitoring._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Arrhythmia Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The increasing occurrence of cardiac disease and other heart-related issues is projected to fuel the expansion of the arrhythmia market going forward. Cardiac disease, or cardiovascular disease, refers to a range of conditions affecting the heart and blood vessels, including ailments such as atherosclerosis, heart attack, stroke, and arrhythmia, among others. A high incidence of heart failure, atrial fibrillation, and other cardiovascular diseases can arise from both functional defects, such as diastolic and systolic dysfunction, and electrical abnormalities, including the development of arrhythmias. For example, in October 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2023, cardiovascular disease was responsible for 919,032 lives, accounting for one in every three deaths. Coronary heart disease remained the most common form of heart disease, and notably, about one in six deaths from cardiovascular diseases occurred among adults younger than 65 years. Therefore, the growing prevalence of cardiac disease and other heart problems is driving the growth of the arrhythmia market._x000D_
_x000D_
#Arrhythmia Market Segment Landscape: Which Areas Lead Development?#_x000D_
The arrhythmia market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias, Other Types_x000D_
2) By Test Equipment: Electrocardiogram (ECG), Holter Monitor_x000D_
3) By Hearth Blocks: First Degree Heart Block, Second Degree Heart Block, Third Degree Heart Block_x000D_
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
_x000D_
Subsegments:_x000D_
1) By Supraventricular Tachycardias: Atrial Fibrillation, Atrial Flutter, Paroxysmal Supraventricular Tachycardia (PSVT) _x000D_
2) By Ventricular Arrhythmias: Ventricular Fibrillation, Ventricular Tachycardia, Premature Ventricular Contractions (PVCs) _x000D_
3) By Bradyarrhythmias: Sinus Bradycardia, Heart Block _x000D_
4) By Other Types: Long QT Syndrome, Wolff-Parkinson-White Syndrome, Torsades de Pointes _x000D_
_x000D_
#Arrhythmia Market Trends Redefining Industry Growth#_x000D_
Leading companies operating in the arrythmia market are developing new catheters to maintain their position. A catheter is a thin, flexible, tube-like medical device inserted into the body to either remove or deliver fluids and medications, or to measure various internal parameters. For instance, in July 2023, Biosense Webster, Inc., a US-based medical equipment manufacturing company, launched the Optrell Mapping Catheter with TrueRef Technology to assist electrophysiologists in mapping complex cardiac arrhythmias. It features a fixed array of small electrodes for high-definition mapping of conditions such as atrial fibrillation and tachycardia. Designed for use with the Carto 3 system by Biosense Webster, this catheter helps identify ablation targets more quickly and effectively. It provides improved diagnostic insight, boosting confidence in detecting ablation targets even in the most complex cases, marking a significant advancement in cardiac electrophysiology._x000D_
_x000D_
#Arrhythmia Market Key Participants And Competitive Landscape#_x000D_
Major companies operating in the arrhythmia market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, AliveCor Inc., Biotronik SE & Co. KG, Biotricity Inc., GE Healthcare, Koninklijke Philips N.V., Nihon Kohden Corporation, Spacelabs Healthcare, Welch Allyn Inc., Mylan N.V., Lepu Medical Technology Co. Ltd., iRhythm Technologies Inc., BioTelemetry Inc., Fukuda Denshi Co. Ltd., Smart Solutions Technologies Inc., Biosense Webster Inc., Cardiac Science Corporation, CardioComm Solutions Inc., CardioNet LLC, NUUBO SMART SOLUTIONS S.L., Cardiva Medical Inc., Osypka AG, Johnson & Johnson Services Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd, Applied Cardiac Systems, Acutus Medical, EP Solutions SA _x000D_
_x000D_
#View The Full Arrhythmia Market Report:#_x000D_
_x000D_
#Arrhythmia Market Geographic Analysis: Where Is Demand Rising Fastest?#_x000D_
North America was the largest region in the arrhythmia market in 2025. The regions covered in the arrhythmia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
